THE BURDEN OF ICS/LABA-TREATED ASTHMA PATIENTS IN THE UK ADULT POPULATION

被引：3
|
作者：
Price, D. [1 ]
Mathieson, N. [2 ]
Mulgirigama, A. [2 ]
Scowcroft, A. [2 ]
Pedersini, R. [3 ]
Isherwood, G. [3 ]
Pavord, I. D. [4 ]
机构：
[1] Univ Aberdeen, Acad Ctr Primary Care, Aberdeen, Scotland
[2] Boehringer Ingelheim Ltd UK, Bracknell, Berks, England
[3] Kantar Hlth, Epsom, Surrey, England
[4] Univ Hosp Leicester NHS Trust, Inst Lung Hlth, Glenfield Hosp, Leicester, Leics, England
来源：
THORAX | 2013年 / 68卷
关键词：
D O I：
10.1136/thoraxjnl-2013-204457.167
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页码：A82 / A82
页数：1
相关论文
共 50 条
  • [21] Predictors of treatment response to high-dose ICS/LABA or medium-dose ICS/LABA plus LAMA in asthma patients - TAILOR study
    Verhamme, K. M.
    De Ridder, M.
    Rijnbeek, P.
    Mosseveld, M.
    Pedersen, L.
    Marconi, E.
    Lapi, F.
    Tan, C.
    Delmestri, A.
    Prieto-Alhambra, D.
    Nudo, E.
    Brusselle, G.
    EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [22] Clinical-functional effectiveness of LABA plus ICS versus LABA plus ICS plus N-acetylcystein in severe bronchial asthma patients
    Yashyna, L.
    Gorovenko, N.
    Polianska, M.
    Moskalenko, S.
    ALLERGY, 2007, 62 : 213 - 213
  • [23] High Healthcare Utilization in a Severe Asthma Population Despite Use of High Dose ICS/LABA
    Castro, M.
    Reaven, N.
    Funk, S.
    Jarjour, N.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2009, 179
  • [24] Economic Burden of Asthma Patients on Medium-to-High-Dosage ICS/LABA, With and Without Exacerbations: US Administrative Claims Database Analyses
    Settipane, Russell A.
    Kreindler, Jim
    Chung, Yen
    Tkacz, Joseph
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2019, 143 (02) : AB53 - AB53
  • [25] Exacerbation Rate Reduction According to Baseline Blood Eosinophilic Count in Patients with Asthma Treated with ICS/LABA Maintenance and Reliever Therapy
    Brusselle, G. G.
    Papi, A.
    Nicolini, G.
    Santoro, L.
    Guastalla, D.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
  • [26] The Burden of Asthma in Subjects Receiving Low-Dose ICS/LABA - an Analysis from a Real World Survey
    Gruffydd-Jones, K.
    Fageras, M.
    Hamblin, A.
    Draffan, L.
    Mestdagh, N.
    Sidaway, M.
    Sheikh, A.
    Small, M.
    Haq, A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 205
  • [27] Medicare Advantage Population in the United States: Outcomes of Patients with Asthma Treated with ICS/LABA Before and After Initiation with Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI)
    Baptist, Alan P.
    Germain, Guillaume
    Klimek, Jacob
    Laliberte, Francois
    Schell, Robert C.
    Forero-Schwanhaeuser, Sergio
    Moore, Alison
    Noorduyn, Stephen G.
    Paczkowski, Rosirene
    ADVANCES IN THERAPY, 2025, 42 (02) : 1061 - 1074
  • [28] Asthma Symptoms And Health Care Resource Utilization By Degree Of Asthma Control In Patients Adherent To Ics/laba Treatment
    Davis, J.
    Trudo, F.
    Siddall, J.
    Bostock, T.
    Small, M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [29] Symptomatic Burden of Asthma Patients Adherent to Medium- or High-Dosage ICS/LABA: Findings From a US Real World Survey
    Trudo, Frank J.
    Davis, Jill R.
    Small, Mark
    Siddall, James
    Pike, James
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2017, 139 (02) : AB97 - AB97
  • [30] The Effectiveness of Combination Therapy of Severe Asthma by Tiotropium with ICS/LABA in Patients with Cold Airway Hyperresponsiveness
    Perelman, J. M.
    Pirogov, A. B.
    Prikhodko, A. G.
    Gassan, D. A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
12345